SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-18-004229
Filing Date
2018-04-13
Accepted
2018-04-13 09:04:55
Documents
146
Period of Report
2018-01-31

Document Format Files

Seq Description Document Type Size
1 20-F summittherapeutics20f2018.htm 20-F 3973965
2 EXHIBIT 4.26 sum-ex426_20180131x20f.htm EX-4.26 1481274
3 EXHIBIT 4.27 sum-ex427_20180131x20f.htm EX-4.27 426506
4 EXHIBIT 4.28 sum-ex428_20180131x20f.htm EX-4.28 486793
5 EXHIBIT 4.29 sum-ex429_20180131x20f.htm EX-4.29 136833
6 EXHIBIT 4.30 sum-ex430_20180131x20f.htm EX-4.30 69189
7 EXHIBIT 4.31 sum-ex431_20180131x20f.htm EX-4.31 423563
8 EXHIBIT 4.32 sum-ex432_20180131x20f.htm EX-4.32 157654
9 EXHIBIT 4.33 sum-ex433_20180131x20f.htm EX-4.33 113880
10 EXHIBIT 8.1 sum-ex81_20180131x20f.htm EX-8.1 10833
11 EXHIBIT 12.1 sum-ex121_20180131x20f.htm EX-12.1 9104
12 EXHIBIT 12.2 sum-ex122_20180131x20f.htm EX-12.2 9051
13 EXHIBIT 13.1 sum-ex131_20180131x20f.htm EX-13.1 9300
14 EXHIBIT 15.1 sum-ex151_20180131x20f.htm EX-15.1 2463
15 a428summitdiscuvashar_image1.jpg GRAPHIC 31129
16 a429taylorvinters.jpg GRAPHIC 5909
17 a431discuvaleasefinal_image1.jpg GRAPHIC 5460
18 chart-859b3e22891c56d8983.jpg GRAPHIC 27544
19 clostridiumdifficilepla01.jpg GRAPHIC 47914
20 compofmeanplasmaa01.jpg GRAPHIC 55673
21 comprecurrratesa01.jpg GRAPHIC 67057
22 devregenaratingfiber.jpg GRAPHIC 172190
23 gutflora500mga01.jpg GRAPHIC 82327
24 patienpopulationspotentially.jpg GRAPHIC 23752
25 profileselectivitya01.jpg GRAPHIC 99512
26 pwcimage.jpg GRAPHIC 4750
27 ridinilazole.jpg GRAPHIC 75042
28 roleofdystrophina01.jpg GRAPHIC 50336
29 summitbardaagreementr_image1.jpg GRAPHIC 69433
30 utropinmodulationa01.jpg GRAPHIC 39004
  Complete submission text file 0001628280-18-004229.txt   19145556

Data Files

Seq Description Document Type Size
31 XBRL INSTANCE DOCUMENT smmt-20180131.xml EX-101.INS 3498738
32 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20180131.xsd EX-101.SCH 101842
33 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT smmt-20180131_cal.xml EX-101.CAL 122688
34 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20180131_def.xml EX-101.DEF 383177
35 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20180131_lab.xml EX-101.LAB 962748
36 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20180131_pre.xml EX-101.PRE 606697
Mailing Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB
Business Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB 44-123-544-3939
Summit Therapeutics plc (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0114
Type: 20-F | Act: 34 | File No.: 001-36866 | Film No.: 18753260
SIC: 2834 Pharmaceutical Preparations